And while most of the current GLP-1 research in addiction focuses on alcohol use disorder, there is also research underway or in progress related to: Nicotine dependence Stimulants (such as cocaine and amphetamines) Opioids (mainly in early and preclinical stages) What Early GLP-1 Addiction Studies Show Clinically What stands out to me clinically is the consistency of the signal emerging around GLP-1 medications and addiction-related cravings
Is Liposomal Glutathione Better Than Other Forms of Glutathione
However, due to their clear outcome definitions, high volume, and statistical analysis, the overall certainty of this effect is high
adults now using or considering these treatments specifically for weight loss, the markets impact is rippling across every corner of the economy
Your provider should: Evaluate your medical history and current health status Order baseline lab work (IGF-1, metabolic panel, hormones) Determine an appropriate starting dose Monitor your progress with follow-up labs and consultations Adjust your protocol based on your response Be proactive in communicating with your provider about your response, any side effects, and your treatment goals
Note that anyone interested in using peptides like CJC 1295 and Ipamorelin should speak with a doctor first to determine their safety for his/her own use and circumstances